The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose up to 20 ...
Data from their most serious competitor, Amgen, suggests the biotech won’t upstage the market leaders.
It’s unclear whether incoming President Donald J. Trump will support outgoing President Joe Biden’s plan to insure the weight ...
Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or ...
The company reported a Phase 2 study of its injectable MariTide medicine showed an approximately 20% average weight loss over ...